Key terms
About VXRT
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded in 2004 and is headquartered in South San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest VXRT news
Mar 20
8:11am ET
Vaxart reports inducement grants under Nasdaq listing rule
Mar 20
7:25am ET
Buy Rating Affirmed for Vaxart Amid Promising Vaccine Trials and Strategic Advancements
Mar 14
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 14, 2024
Mar 11
8:00am ET
Options Volatility and Implied Earnings Moves This Week, March 11 – March 15, 2024
Mar 06
9:32am ET
Vaxart Inc Welcomes Steven Lo as New CEO and President
Mar 06
8:07am ET
Vaxart appoints Steven Lo as President, CEO, Director
Feb 29
4:43pm ET
Vaxart Inc Launches New Equity Plan to Attract Talent
Feb 23
11:04am ET
Biotech Alert: Searches spiking for these stocks today
Feb 15
4:23pm ET
Vaxart Regains Compliance with Nasdaq Listing Standards
Feb 05
8:13am ET
Vaxart announces publication of preclinical data on vaccine candidates
Feb 02
11:07am ET
Biotech Alert: Searches spiking for these stocks today
Jan 31
7:51am ET
Vaxart upgraded to Buy on government funding at B. Riley
Jan 31
7:40am ET
Analysts’ Top Healthcare Picks: Vaxart (VXRT), Palisade Bio (PALI)
Jan 31
7:22am ET
Vaxart upgraded to Buy from Neutral at B. Riley
Jan 19
11:24am ET
Biotech Alert: Searches spiking for these stocks today
Jan 19
8:31am ET
Vaxart receives $9.27M BARDA project award for Phase 2B trial on oral pill
Jan 18
11:32am ET
Biotech Alert: Searches spiking for these stocks today
No recent news articles are available for VXRT
No recent press releases are available for VXRT
VXRT Financials
Key terms
Ad Feedback
VXRT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VXRT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range